Skip Nav Destination
Issues
September 2018
-
Cover Image
Cover Image
Cover: Credit: Sandra Dionisi. For more information, please visit theispot.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care August 2018, Vol.41, 1833-1834. doi:https://doi.org/10.2337/dc18-ti09
Perspectives in Care
Considerations in Epidemiologic Definitions of Undiagnosed Diabetes
Diabetes Care August 2018, Vol.41, 1835-1838. doi:https://doi.org/10.2337/dc17-1838
Commentaries
Increasing Hospitalizations for DKA: A Need for Prevention Programs
Diabetes Care August 2018, Vol.41, 1839-1841. doi:https://doi.org/10.2337/dci18-0004
Is Mini-Dose Glucagon the Answer to Preventing Exercise-Related Dysglycemia?
Diabetes Care August 2018, Vol.41, 1842-1843. doi:https://doi.org/10.2337/dci18-0024
Clinical Care / Education / Nutrition / Psychosocial Research
Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
John M. Dennis; William E. Henley; Michael N. Weedon; Mike Lonergan; Lauren R. Rodgers; Angus G. Jones; William T. Hamilton; Naveed Sattar; Salim Janmohamed; Rury R. Holman; Ewan R. Pearson; Beverley M. Shields; Andrew T. Hattersley; MASTERMIND Consortium
Diabetes Care August 2018, Vol.41, 1844-1853. doi:https://doi.org/10.2337/dc18-0344
High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort
Behiye Özcan; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Femke Rutters; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Frank J. Snoek; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Mandy Roosendaal; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Eric J. Sijbrands; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Petra J.M. Elders; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Frits Holleman; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Hanno Pijl; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Cees J. Tack; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Evertine J. Abbink; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Harold W. de Valk; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Bruce H.R. Wolffenbuttel; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Coen D.A. Stehouwer; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Nicholas C. Schaper; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Jacqueline M. Dekker; on behalf of the Diabetes Pearl from the Parelsnoer Initiative; Miranda T. Schram; on behalf of the Diabetes Pearl from the Parelsnoer Initiative
Diabetes Care June 2018, Vol.41, 1854-1861. doi:https://doi.org/10.2337/dc17-2181
T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes
Lawrence Fisher; Danielle Hessler; William H. Polonsky; Umesh Masharani; Susan Guzman; Vicky Bowyer; Lisa Strycker; Andrew Ahmann; Marina Basina; Ian Blumer; Charles Chloe; Sarah Kim; Anne L. Peters; Martha Shumway; Karen Weihs; Patricia Wu
Diabetes Care July 2018, Vol.41, 1862-1869. doi:https://doi.org/10.2337/dc18-0391
Epidemiology / Health Services Research
Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study
Diabetes Care January 2018, Vol.41, 1870-1877. doi:https://doi.org/10.2337/dc17-1583
Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking
David A. Jenkins; Jack Bowden; Heather A. Robinson; Naveed Sattar; Ruth J.F. Loos; Martin K. Rutter; Matthew Sperrin
Diabetes Care July 2018, Vol.41, 1878-1886. doi:https://doi.org/10.2337/dc17-2508
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
Maria J. Redondo; Susan Geyer; Andrea K. Steck; Seth Sharp; John M. Wentworth; Michael N. Weedon; Peter Antinozzi; Jay Sosenko; Mark Atkinson; Alberto Pugliese; Richard A. Oram; Type 1 Diabetes TrialNet Study Group
Diabetes Care July 2018, Vol.41, 1887-1894. doi:https://doi.org/10.2337/dc18-0087
Effects of High Blood Pressure on Cardiovascular Disease Events Among Chinese Adults With Different Glucose Metabolism
Jingyan Tian; Chang-Sheng Sheng; Weihong Sun; Xiaomin Song; Haiyan Wang; Qifang Li; Wenyi Li; Weiqing Wang
Diabetes Care July 2018, Vol.41, 1895-1900. doi:https://doi.org/10.2337/dc18-0918
Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study
Daniele Massera; Mary L. Biggs; Marcella D. Walker; Kenneth J. Mukamal; Joachim H. Ix; Luc Djousse; Rodrigo J. Valderrábano; David S. Siscovick; Russell P. Tracy; Xiaonan Xue; Jorge R. Kizer
Diabetes Care July 2018, Vol.41, 1901-1908. doi:https://doi.org/10.2337/dc18-0849
Emerging Therapies: Drugs and Regimens
Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes
Michael R. Rickels; Stephanie N. DuBose; Elena Toschi; Roy W. Beck; Alandra S. Verdejo; Howard Wolpert; Martin J. Cummins; Brett Newswanger; Michael C. Riddell; T1D Exchange Mini-Dose Glucagon Exercise Study Group
Diabetes Care May 2018, Vol.41, 1909-1916. doi:https://doi.org/10.2337/dc18-0051
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Michael J. Haller; Desmond A. Schatz; Jay S. Skyler; Jeffrey P. Krischer; Brian N. Bundy; Jessica L. Miller; Mark A. Atkinson; Dorothy J. Becker; David Baidal; Linda A. DiMeglio; Stephen E. Gitelman; Robin Goland; Peter A. Gottlieb; Kevan C. Herold; Jennifer B. Marks; Antoinette Moran; Henry Rodriguez; William Russell; Darrell M. Wilson; Carla J. Greenbaum; Type 1 Diabetes TrialNet ATG-GCSF Study Group
Diabetes Care July 2018, Vol.41, 1917-1925. doi:https://doi.org/10.2337/dc18-0494
A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin
Ildiko Lingvay; Cyrus V. Desouza; Katarina S. Lalic; Ludger Rose; Thomas Hansen; Jeppe Zacho; Thomas R. Pieber
Diabetes Care July 2018, Vol.41, 1926-1937. doi:https://doi.org/10.2337/dc17-2381
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Chantal Mathieu; Paresh Dandona; Pieter Gillard; Peter Senior; Christoph Hasslacher; Eiichi Araki; Marcus Lind; Stephen C. Bain; Serge Jabbour; Niki Arya; Lars Hansen; Fredrik Thorén; Anna Maria Langkilde; DEPICT-2 Investigators
Diabetes Care July 2018, Vol.41, 1938-1946. doi:https://doi.org/10.2337/dc18-0623
Pathophysiology / Complications
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
Andreas Heinzel; for the BEAt-DKD Consortium; Michael Kammer; for the BEAt-DKD Consortium; Gert Mayer; for the BEAt-DKD Consortium; Roman Reindl-Schwaighofer; for the BEAt-DKD Consortium; Karin Hu; for the BEAt-DKD Consortium; Paul Perco; for the BEAt-DKD Consortium; Susanne Eder; for the BEAt-DKD Consortium; Laszlo Rosivall; for the BEAt-DKD Consortium; Patrick B. Mark; for the BEAt-DKD Consortium; Wenjun Ju; for the BEAt-DKD Consortium; Matthias Kretzler; for the BEAt-DKD Consortium; Peter Gilmour; for the BEAt-DKD Consortium; Jonathan M. Wilson; for the BEAt-DKD Consortium; Kevin L. Duffin; for the BEAt-DKD Consortium; Moustafa Abdalla; for the BEAt-DKD Consortium; Mark I. McCarthy; for the BEAt-DKD Consortium; Georg Heinze; for the BEAt-DKD Consortium; Hiddo L. Heerspink; for the BEAt-DKD Consortium; Andrzej Wiecek; for the BEAt-DKD Consortium; Maria F. Gomez; for the BEAt-DKD Consortium; Rainer Oberbauer; for the BEAt-DKD Consortium
Diabetes Care July 2018, Vol.41, 1947-1954. doi:https://doi.org/10.2337/dc18-0532
Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark
Signe T. Andersen; Daniel R. Witte; Henning Andersen; Lasse Bjerg; Niels Henrik Bruun; Marit E. Jørgensen; Nanna B. Finnerup; Torsten Lauritzen; Troels S. Jensen; Hatice Tankisi; Morten Charles
Diabetes Care July 2018, Vol.41, 1955-1962. doi:https://doi.org/10.2337/dc18-0392
Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
M. Loredana Marcovecchio; Scott T. Chiesa; Jane Armitage; Denis Daneman; Kim C. Donaghue; Timothy W. Jones; Farid H. Mahmud; Sally M. Marshall; H. Andrew W. Neil; R. Neil Dalton; John Deanfield; David B. Dunger; Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Study Group
Diabetes Care July 2018, Vol.41, 1963-1969. doi:https://doi.org/10.2337/dc18-1125
Cardiovascular and Metabolic Risk
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
John B. Buse; Satish K. Garg; Julio Rosenstock; Timothy S. Bailey; Phillip Banks; Bruce W. Bode; Thomas Danne; Jake A. Kushner; Wendy S. Lane; Pablo Lapuerta; Darren K. McGuire; Anne L. Peters; John Reed; Sangeeta Sawhney; Paul Strumph
Diabetes Care June 2018, Vol.41, 1970-1980. doi:https://doi.org/10.2337/dc18-0343
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Thomas Danne; Bertrand Cariou; Phillip Banks; Michael Brandle; Helmut Brath; Edward Franek; Jake A. Kushner; Pablo Lapuerta; Darren K. McGuire; Anne L. Peters; Sangeeta Sawhney; Paul Strumph
Diabetes Care June 2018, Vol.41, 1981-1990. doi:https://doi.org/10.2337/dc18-0342
The Impact of Glycated Hemoglobin (HbA1c) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank
Diabetes Care June 2018, Vol.41, 1991-1997. doi:https://doi.org/10.2337/dc18-0289
Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults
Tiansheng Wang; Jin-Liern Hong; Emily W. Gower; Virginia Pate; Seema Garg; John B. Buse; Til Stürmer
Diabetes Care July 2018, Vol.41, 1998-2009. doi:https://doi.org/10.2337/dc17-2285
Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register
Stephanie H. Read; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Merel van Diepen; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Helen M. Colhoun; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Nynke Halbesma; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Robert S. Lindsay; on behalf of the Scottish Diabetes Research Network Epidemiology Group; John A. McKnight; on behalf of the Scottish Diabetes Research Network Epidemiology Group; David A. McAllister; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Ewan R. Pearson; on behalf of the Scottish Diabetes Research Network Epidemiology Group; John R. Petrie; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Sam Philip; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Naveed Sattar; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Mark Woodward; on behalf of the Scottish Diabetes Research Network Epidemiology Group; Sarah H. Wild; on behalf of the Scottish Diabetes Research Network Epidemiology Group
Diabetes Care July 2018, Vol.41, 2010-2018. doi:https://doi.org/10.2337/dc18-0578
Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes
Ahmed Al-Badri; Zeba Hashmath; Garrett H. Oldland; Rachana Miller; Khuzaima Javaid; Amer Ahmed Syed; Bilal Ansari; Swetha Gaddam; Walter R. Witschey; Scott R. Akers; Julio A. Chirinos
Diabetes Care July 2018, Vol.41, 2019-2025. doi:https://doi.org/10.2337/dc18-0324
Position Statement
Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
Jane L. Chiang; David M. Maahs; Katharine C. Garvey; Korey K. Hood; Lori M. Laffel; Stuart A. Weinzimer; Joseph I. Wolfsdorf; Desmond Schatz
Diabetes Care August 2018, Vol.41, 2026-2044. doi:https://doi.org/10.2337/dci18-0023
Standards of Care Updates
Updates to the Standards of Medical Care in Diabetes—2018
Diabetes Care August 2018, Vol.41, 2045-2047. doi:https://doi.org/10.2337/dc18-su09
Errata
Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
Leo F. Buckley; Dave L. Dixon; George F. Wohlford, IV; Dayanjan S. Wijesinghe; William L. Baker; Benjamin W. Van Tassell
Diabetes Care June 2018, Vol.41, 2048. doi:https://doi.org/10.2337/dc18-er09
Issues and Events
e-Letters
Observations
Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database
Diabetes Care July 2018, Vol.41, e130-e132. doi:https://doi.org/10.2337/dc18-0210
Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
Jakob Schöllhammer Knudsen; Reimar Wernich Thomsen; Anton Pottegård; Filip Krag Knop; Henrik Toft Sørensen
Diabetes Care July 2018, Vol.41, e133-e135. doi:https://doi.org/10.2337/dc18-0999
Comments and Responses
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192
Diabetes Care August 2018, Vol.41, e137-e138. doi:https://doi.org/10.2337/dci18-0026
